15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (5) , 3217-3223
- https://doi.org/10.1074/jbc.m411221200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Tumor Growth Inhibition by Indomethacin in a Mouse Model of Human Medullary Thyroid Cancer: Implication of Cyclooxygenases and 15-Hydroxyprostaglandin DehydrogenaseEndocrinology, 2004
- Prostaglandin E2 Synergistically Enhances Receptor Tyrosine Kinase-dependent Signaling System in Colon Cancer CellsJournal of Biological Chemistry, 2004
- Prostaglandin E2 as a mediator of fever: synthesis and catabolismFrontiers in Bioscience-Landmark, 2004
- Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasionCancer Cell, 2003
- Frontiers in cancer prevention research.2003
- Cyclooxygenase-2 and Colorectal CancerPublished by S. Karger AG ,2003
- EGF, TGF-a, and EGF-R in Human Colorectal AdenocarcinomaActa Oncologica, 1998
- Chromosomal localization of the type-I 15-PGDH gene to 4q34-q35Human Genetics, 1997
- Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1994
- Altered eicosanoid levels in human colon cancer.1993